Leukocytoclastic vasculitis in a patient with metastatic synovial sarcoma: A case report and review of the literatüre
PDF
Cite
Share
Request
Case report
P: 145-150
2016

Leukocytoclastic vasculitis in a patient with metastatic synovial sarcoma: A case report and review of the literatüre

Acta Haematol Oncol Turc 2016;49(2):145-150
1. Ankara Ataturk Training And Research Hospital, Department of Medical Oncology, Ankara, Turkey
2. Yildirim Beyazit University, Faculty of Medicine, Ataturk Research and Training Hospital Department Of Internal Medicine, Ankara, Turkey
3. Yildirim Beyazit University, Faculty of Medicine, Ataturk Research and Training Hospital Department Of Medical Oncology, Ankara, Turkey
4. Ankara Ataturk Training and Research Hospital, Department of Pathology, Ankara, Turkey
5.
No information available.
No information available
Received Date: 2016-01-14T19:40:41
Accepted Date: 2016-06-02T10:44:49
PDF
Cite
Share
Request

Abstract

We described a case that synovial sarcoma with lung metastasis, presenting with leukocytoclastic vasculitis after treatment with high dose ifosfamide. Forty-two years old male patient was admitted to the hospital due to anteromedial mass on his left arm. He was operated with the diagnosis of high grade synovial sarcoma and he received adjuvant treatment. 10 months later after the end of the therapy, numerous metastatic lung nodules developed and started high dose ifosfamide treatment. Stomachache, hematuria, erythematous lesions, palpable purpura on his bilateral lower extremities developed after 1weeks later of the starting chemotherapy. His autoantibodies were negative (anticardiolipin IG G/M, antiphospholipid Ig G/ M, antids DNA, ANA, pANCA, cANCA) and RF, C3, C4 were normal. Full-thickness skin biopsy resulted as leukocytoclastic vasculitis. After treatment 1 mg/kg prednisolone, patient's rash, hematuria, abdominal pain disappeared completely. We found that a possible relationship between ifosfamide and vasculitis according to Naranjo scale which envisioning the possibility of drug induced adverse drug effects. In the light of current knowledge, we found no cases developing leukocytoclastic vasculitis after ifosfamide treatment in the literature. Here, we wanted to emphasize that in patients treated with high dose ifosfamide might develop leukocytoclastic vasculitis, which is rare and unusual case.